|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,205 JPY | +0.47% |
|
+1.26% | -1.99% |
| Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
| Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Mochida Pharmaceutical Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects net sales to be JPY 104,000 million. Operating income to be JPY 8,500 million.
Profit attributable to owners of parent to be JPY 6,300 million. Net income per share to be JPY 172.45.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.99% | 719M | |
| +32.88% | 704B | |
| +28.59% | 577B | |
| -3.63% | 348B | |
| +18.33% | 327B | |
| +5.10% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -4.12% | 147B |
MOCHIDA PHARMACEUTICAL CO., LTD. 
